Effects of equine-assisted therapy on transdiagnostic consequences of aversive childhood experiences

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034951

Enrollment

Registered

2024-08-26

Start date

2024-09-03

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients aged 18-60 years with aversive childhood experiences, measured by CTQ (F3x, F4x, F5x, F6x). Exclusion criteria are organic, including symptomatic mental disorders (F00-F09), autism (F84), schizophrenia, schizotypal and delusional disorders (F20-F29) and substance and alcohol abuse in the last 2 weeks

Interventions

Group 1: Equine-assisted intervention with two Shetland Ponys (6 sessions of 60 minutes over 6 weeks, group size: 4 participants) Group 2: Active control group: Behavioral Activation (6 sessions of 60

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients aged 18-60 years with aversive childhood experiences, measured by CTQ (subscales: emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect); Severity: min. “moderate to severe” on one of the subscales

Exclusion criteria

Exclusion criteria: ? Acute suicidal tendencies ? Organic, including symptomatic mental disorders (F00-F09) ? Substance and alcohol abuse in the last 2 weeks ? Autism (F84) ? Schizophrenia, schizotypal and delusional disorders (F20-F29) ? Placement according to PsychKG ? Pregnancy ? Epilepsy (G40) ? Immobility (R26) ? Horse hair allergy

Design outcomes

Primary

Measure	Time frame
1) Patient's subjective self-efficacy, determined using the General Self-Efficacy Scale (GSE) before intervention, after 4, 6 and 12 weeks 2) Patient's subjective treatment satisfaction, determined using a semi-structured interview after 6 weeks	—

Secondary

Measure	Time frame
Part A: Changes in global level of functioning, quality of life, diagnosis-overarching symptoms, emotional competence and mindfulness, assessed using GAF, WHOQOL-BREF, BSI, SEK-27 and MASS before therapy, after 4, 6 and 12 weeks Part B: Patient's subjective treatment adherence and motivation, determined using a semi-structured interview after 6 weeks	—

Countries

Germany

Contacts

Public ContactIrina Papazova

Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Universität Augsburg BKH Augsburg

irina.papazova@med.uni-augsburg.de+49 (0)821 4803-1202

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026